Entity
  • Sim&Cure

    Created in 2014
  • BETA

    Up & running (A)
    Existing signals show a regular activity
  • Social networks

    1,082 5,952 5,952
  • Activities

  • Technologies

  • Entity types

  • Location

    95 Rue Pierre Flourens, 34090 Montpellier, France

    Montpellier

    France

  • Employees

    Scale: 51-200

    Estimated: 65

  • SIREN

    803695402
  • Engaged corporates

    4
    3 2
  • Added in Motherbase

    1 year ago
Description
  • Value proposition

    Shaping the future of endovascular treatments.
    For more information about our products, visit our website!

    Founded in 2014 and located in the vibrant Medtech ecosystem in Montpellier, France, Sim&Cure is a digital start-up focused on Improving patient outcome and physician experience of endovascular treatment by combining Digital Twin and AI Technologies. As new technologies progress through the medical network, S&C will help its partners to flatten the learning curve. Sim&Cure's philosophy focuses on driving innovation in the healthcare industry and helping to improve treatments strategies in order to secure patient care.

    Sim&Cure has won the prestigious i-Lab national contest twice in 2014 and 2015 and i-Nov in 2020.
    The start-up is backed by the Seed Fund IT-Translation and Elaia Partners
    Sim&Cure has established scientific and clinical collaborations with leading laboratories and hospitals around the world.

    Sim&Cure opened a subsidiary in US (NY) in July 2019.
    The company employs 50 people and anticipates a phase of strong growth.



    medical software, medical devices, patient-specific, start-up, endovascular treatments, innovation, and neurovascular

  • Original language

    Shaping the future of endovascular treatments.
    For more information about our products, visit our website!

    Founded in 2014 and located in the vibrant Medtech ecosystem in Montpellier, France, Sim&Cure is a digital start-up focused on Improving patient outcome and physician experience of endovascular treatment by combining Digital Twin and AI Technologies. As new technologies progress through the medical network, S&C will help its partners to flatten the learning curve. Sim&Cure's philosophy focuses on driving innovation in the healthcare industry and helping to improve treatments strategies in order to secure patient care.

    Sim&Cure has won the prestigious i-Lab national contest twice in 2014 and 2015 and i-Nov in 2020.
    The start-up is backed by the Seed Fund IT-Translation and Elaia Partners
    Sim&Cure has established scientific and clinical collaborations with leading laboratories and hospitals around the world.

    Sim&Cure opened a subsidiary in US (NY) in July 2019.
    The company employs 50 people and anticipates a phase of strong growth.

Corporate interactions BETA
Corporate TypeTweets Articles
Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration
Other

29 Mar 2024


Créalia Occitanie
Créalia Occitanie
Civic and Social Organizations
Créalia Occitanie
Civic and Social Organizations
Other

24 Jul 2023


Entreprendre à Montpellier
Entreprendre à Montpellier
Startup accelerator & VC, Government Administration
Entreprendre à Montpellier
Startup accelerator & VC, Government Administration
Other

16 Jun 2023


Elaia
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals
Elaia
Startup accelerator & VC, Venture Capital and Private Equity Principals
Other

22 Sep 2023


Similar entities
Loading...
Loading...
Social network dynamics